Product Name:Ethyl 7-nitro-5-(trifluoromethyl)benzo[d]thiazole-2-carboxylate
IUPAC Name:ethyl 7-nitro-5-(trifluoromethyl)-1,3-benzothiazole-2-carboxylate
| Packing Unit | Available Stock | Price($) | Quantity |
|---|---|---|---|
| CM154795-250mg | in stock | ưƎțŴ |
|
|
|||
| Product Overview |
Ethyl 7-nitro-5-(trifluoromethyl)benzo[d]thiazole-2-carboxylate is a chemical compound that has gained significant attention in scientific research due to its potential applications in various fields. It is a synthetic compound that belongs to the class of benzo[d]thiazole derivatives. |
| Synthesis and Application |
The synthesis of Ethyl 7-nitro-5-(trifluoromethyl)benzo[d]thiazole-2-carboxylate involves the reaction of 5-(trifluoromethyl)benzo[d]thiazole-2-carboxylic acid with ethyl nitrate in the presence of a suitable catalyst. The reaction is carried out under controlled conditions of temperature and pressure, and the product is purified using various techniques such as column chromatography, recrystallization, and distillation. Ethyl 7-nitro-5-(trifluoromethyl)benzo[d]thiazole-2-carboxylate has potential applications in various fields of scientific research. It has been studied for its anti-cancer, anti-inflammatory, anti-bacterial, and anti-viral properties. It has also been investigated for its potential use as a fluorescent probe in bioimaging and as a catalyst in organic synthesis. |
| Future Directions |
There are several future directions for the research on Ethyl 7-nitro-5-(trifluoromethyl)benzo[d]thiazole-2-carboxylate. One area of interest is its potential use as a fluorescent probe in bioimaging. Further studies are needed to optimize its fluorescent properties and evaluate its performance in various biological systems. Another area of future research is its potential use as a catalyst in organic synthesis. Studies are needed to explore its catalytic activity and selectivity in various reactions. Additionally, further studies are needed to elucidate its mechanism of action and pharmacological properties, which could lead to the development of novel therapeutic agents. |
Search 
+86 21 5895 0110 
